TrialBone marrow transplantation2012

Differential impact of inhibitory and activating Killer Ig-Like Receptors (KIR) on high-risk patients with myeloid and lymphoid malignancies undergoing reduced intensity transplantation from haploidentical related donors.

D-F Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.